Atacand

Blood pressure drug helps kidney patients - study

Thursday, February 12th, 2009

Source: Reuters
Large doses of AstraZeneca’s high blood pressure drug Atacand (candesartan) may protect people with kidney disease from developing kidney failure and the need for dialysis or a transplant, researchers said on Wednesday.
Daily doses of eight times the normal amount of the drug, also known as candesartan, lowered abnormal amounts of protein in the urine, called [...]

Long-term use of a hypertension drug may reduce symptoms of heart disease

Friday, January 2nd, 2009

Long-term use of a hypertension drug may reduce symptoms of heart disease
Research team led by Dr. Jiri Krupicka of Na Homolce Hospital in Prague, the Czech Republic conducted a double-blind, placebo-controlled, randomized study to the effect of the long-term administration of candesartan - marketed by AstraZeneca and Takeda as Atacand and BioPress respectively - on [...]